EP4490267A1 - Cells derived from polypedilum vanderplanki and odor sensor equipped therewith - Google Patents
Cells derived from polypedilum vanderplanki and odor sensor equipped therewithInfo
- Publication number
- EP4490267A1 EP4490267A1 EP23767510.3A EP23767510A EP4490267A1 EP 4490267 A1 EP4490267 A1 EP 4490267A1 EP 23767510 A EP23767510 A EP 23767510A EP 4490267 A1 EP4490267 A1 EP 4490267A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- cells
- orco
- protein
- exogenous
- odor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0601—Invertebrate cells or tissues, e.g. insect cells; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
Definitions
- the present disclosure generally relates to cells derived from Polypedilum vanderplanki expressing an exogenous membrane protein, an odor sensor comprising cells expressing odorant receptors (ORs), and methods for detecting an odor using cells expressing ORs.
- BACKGROUND [0004] Polypedilum vanderplanki is a drought-tolerant insect, and it is known that even if its larvae have almost completely lost the water in their bodies and become dehydrated, if they are returned to water, they will resume growth as if nothing had happened.
- cultured cells derived from Polypedilum vanderplanki are also underway; for example, cultured cells Pv11 are known to survive and resume proliferation after rehydration even when stored dry at room temperature for over a year (K. Watanabe et al. Cryobiology 73 (2016) 93-98). It is also known that the Pv11 cells protect the activity of enzymes in the cytoplasm even after long-term drying (Kikuta et al. "Towards water-free biobanks: long-term dry-preservation at room temperature of drying sensitive enzyme luciferase in airdried insect cells” Scientific Reports, 2017 (Published online 26 July 2017)).
- biodevice having an odor detection function equivalent to the olfactory sense of animals devices are being developed wherein cells that detect specific odors are arranged in an array, the response signals of the cells to the odor are detected, amplified, integrated with AI, and the like, and the composition of the odor is displayed.
- an odor sensor As a device, an odor sensor has been developed wherein an olfactory receptor protein (Or), which is an insect membrane protein; olfactory receptor protein co-receptor (Orco), which together with Or constitutes a cation channel; and GCaMP (GFP-based Ca 2+- calmodulin protein; Nature Biotechnology volume 19, pages 137-141 (2001)), which is a fluorescent marker protein that detects changes in intracellular calcium concentration, were expressed in insect culture cells Sf21, the cells are arranged in an array and a specific signal pattern is detected for a particular odorant (Japanese Patent Application Publication No.2013-27376).
- Or olfactory receptor protein
- Orco olfactory receptor protein co-receptor
- the present disclosure relates to an OR-based sensor system for detection of one or more odorant molecules using cells derived from Polypedilum vanderplanki expressing at least one exogenous membrane protein, wherein the exogenous membrane protein, such as an olfactory receptor protein, functions even when the cells are dried and then rehydrated.
- the present disclosure provides cells derived from Polypedilum vanderplanki expressing at least one exogenous membrane protein.
- the cells are insect cells, such as for example, the insect cell line Pv11.
- the exogenous membrane protein comprises an olfactory receptor protein (“Or”) and/or an olfactory receptor co-receptor (“Orco”) protein.
- expression of the exogenous membrane protein gene is operably linked to the 121 promoter.
- OR refers to a receptor translocated to the cell membrane after expression that is capable of detecting an odorant.
- ORs consist of a tetramer of two heptahelical subunits: a highly variable Or subunit that confers odor specificity (“olfactory receptor protein”; “Or”) and a co-receptor subunit, Orco that is highly conserved across insect species [23].
- This hetero-complex forms an ion channel that is gated by odorant binding, directly allowing Na + and Ca 2+ influx.
- odorant comprises any molecule that activates an olfactory receptor. Such odorants are very diverse and include pleasant and unpleasant odorants. The molecule that elicits the greatest response from an OR is referred to as its cognate ligand.
- an “odor” comprises a mixture of odorants. Scents such as from food or coffee are odors. In applications outside of the laboratory, odorants are also found as components of odors since they are present in a background environment of other odorants.
- ORs bind not just their cognate ligands, but other odorants also; an OR is considered broadly tuned if it binds a large number of odorants, and narrowly tuned if it binds a small number. Binding may lead not only to activation or excitation of the OR, but also to inhibition. Responses to mixtures are not simply linear and additive: the presence of a second odorant, even if it does not activate an OR, can modulate the response of the OR to another odorant.
- a large number of ORs and combinatorial coding allows olfactory systems to respond to odors beyond their natural stimuli. For example, insects can distinguish explosives, drugs, and breast cancer. Biologically relevant concentrations cover a large range.
- ORs bind chemicals in a concentration-dependent manner and exhibit different affinities, and in general insect ORs are broadly tuned although they are most sensitive to structurally similar odorants (E. A. Hallem and J. R. Carlson, "Coding of odors by a receptor repertoire," Cell, 125 (1), 143-160 (2006), 10.1016/j.cell.2006.01.050).
- the recruitment, with increasing concentration, of broadly tuned ORs that have lower affinity is an important principle that extends the dynamic range of the olfactory system.
- An advantage associated with the use of Pv11 cells is that said cells are cultured at room temperature without special atmospheric conditions (e.g., CO 2 ).
- the engineered insect cells may express one or more additional exogenous proteins.
- Exogenous protein refers to a protein not naturally present in a particular organism, tissue or cell, for example, a protein from a different species.
- An “exogenous protein” may be a protein that is the expression product of an exogenous expression construct or transgene, or a protein not naturally present in a given quantity in a particular tissue or cell.
- exogenous proteins may comprise a marker protein that detects activation of the olfactory receptor protein expressed within the cell. Such activation may result in changes in intracellular calcium concentration.
- the marker protein may include, for example, a fluorescent marker protein, e.g. a fluorescent calcium-sensing molecule.
- Cells having an activated OR will fluoresce and may be detectable by reading in an appropriate machine, such as a luminometer or fluorometer.
- the present disclosure further provides an odor biosensor, comprising cells derived from Polypedilum vanderplanki expressing an Or and/or Orco.
- the Or proteins are derived from insect cells.
- the odor biosensor cells are derived from Polypedilum vanderplanki and express the Or and/or Orco.
- the cells may further express a fluorescent marker protein that detects changes in intracellular calcium concentration.
- the odor sensor cells are immobilized on a chip.
- the present disclosure further provides an odor detection method comprising the steps of (a) providing biosensor cells expressing at least one Or and/or Orco and exposing the biosensor cells to at least one test compound or sample and (b) detecting a signal that indicates activation of the one or more ORs in the biosensor cells.
- the detected signal is a change in intracellular calcium concentrations.
- the change in intracellular calcium concentration is detected through the use of a marker protein that detects changes in intracellular calcium concentration, e.g., a fluorescent calcium-sensing molecule.
- the biosensor cells expressing one or more ORs are placed in an assay plate, such as a 96-well plate or similar type plate and exposed to a test sample.
- the odor sensor cells are immobilized on a substrate, such as a glass slide or CMOS chip.
- multi-OR sensor arrays may be utilized to determine responses to odorants singly or in mixtures.
- the biosensors provided herein may be used to detect odors from industry and livestock that can be detrimental to workers and nearby populations.
- the biosensors can be used to identify compounds for use in pest management.
- Biosensors may also be utilized for food safety; non- invasive medical diagnostics and health monitoring; detecting explosives and illicit drugs; detecting food spoilage; used in the production and authentication of perfumes, food products, beverages, wines, beer, and the like, detection of counterfeit food and perfume products; and used in search and rescue operations.
- the biosensors may be used in the production and/or authentication of chocolate, wine, and olive oil.
- there are many diseases transmitted by insect vectors including sleeping sickness, river blindness, and Chagas disease.
- the biosensors disclosed herein may be used to identify compounds for use in control of diseases transmitted by insect vectors.
- the present disclosure provides devices for detecting the presence of a particular odorant or for identifying an odor comprising biosensor cells expressing one or more ORs that are activated upon exposure to particular odorant molecules.
- the device is a handheld device.
- the device is capable of communicating to a user of the device that a specific odorant has been detected or that an odor has been identified.
- kits for detection of an odorant or identification of an odor using one or more biosensor cells comprise a panel of heterologous cells each expressing a particular OR.
- the kits may include instructions for using the kit.
- the kits may also comprise buffers, and signal producing and detection systems.
- a method of preserving an exogenous membrane protein comprising: a step of introducing a gene encoding the exogenous membrane protein into a cell derived from Polypedilum vanderplanki, a step of culturing the cell to express the exogenous membrane protein in the cell membrane, and a step of drying the cells.
- the method may further comprise, prior to the drying step, a step of suspending the cells in a solution comprising a dry protection agent.
- a step of suspending the cells in a solution comprising a dry protection agent can be provided that express exogenous membrane proteins that can be stored at room temperature after drying, and that can be rehydrated and conveniently used when necessary. Therefore, for example, if Or and Orco are employed as the exogenous membrane proteins, a portable odor biosensor can be produced, and it can be used for food hygiene control and food quality evaluation.
- FIG.1 is a schematic diagram showing one aspect of a cell according to the present disclosure.
- FIG.2 is a schematic diagram of the gene organization in the generation of Pv11- GCaMP6 f-Orco-OR47a stable expression cell line (Orco OR47a stable expression cell line).
- FIG.3 is a graph showing fluorescence intensity when a cell line stable expression Orco-OR47a is brought into contact with VUAA1 (N-(4-ethylphenyl)-2- ⁇ [4-ethyl-5- (pyridin-3-yl)-4H-1,2,4-triazol-3-yl]sulfanyl ⁇ acetamide), an agonist of Orco.
- VUAA1 N-(4-ethylphenyl)-2- ⁇ [4-ethyl-5- (pyridin-3-yl)-4H-1,2,4-triazol-3-yl]sulfanyl ⁇ acetamide
- FIG.4 is a graph showing the fluorescence intensity when a cell line stable expression Orco-OR47a is brought into contact with pentyl acetate, which is a ligand of OR47a (ns: non-significant, ***: P ⁇ 0.0001).
- FIG.5 is a graph showing the viability 1 hour after drying and rehydrating Pv11 wild type (Pv11), Pv11-GCaMP6 f-Orco stable expression cell line (Orco stable expression cell line) and Orco-OR47a stable expression cell line.
- FIG.6A-B is a graph showing the fluorescence intensity when a cell line stable expression Orco-OR47a is brought into contact with pentyl acetate, which is a ligand of OR47a (ns: non-significant, ***: P ⁇ 0.0001).
- FIG.6A is a graph showing the response function to VUAA1, pentyl acetate, and acetophenone of the Orco-OR47a stable expression cell line as a change in fluorescence intensity before dehydration treatment (**: p ⁇ 0.01, * **: p ⁇ 0.001).
- FIG. 6B is a graph showing the response function to VUAA1 and pentyl acetate of the Orco-OR47a stable expression cell line as a change in fluorescence intensity after 1 hour of rehydration after drying (***: p ⁇ 0.001, ****: p ⁇ 0.0001). [00032]
- FIG.7A-D FIG. 7A.
- FIG. 7B is a graph showing the response function to pentyl acetate of the Orco-OR47a stable expression cell line as a change in fluorescence intensity after 1 hour of drying and rehydration. It was treated with CHX (protein synthesis inhibitor) as in FIG.7A (ns: non-significant).
- FIG.7C is a graph showing the response function to VUAA1 of the Orco-OR47a stable expression cell line as a change in fluorescence intensity after 24 hours of drying and rehydration. It was treated with CHX (protein synthesis inhibitor) as in FIG.7A (* * * *: p ⁇ 0.0001).
- FIG. 7D is a graph showing the response function of the Orco-OR47a stable expression cell line 1 hour after rehydration and 24 hours after drying. It was treated with CHX (protein synthesis inhibitor) as in FIG.7A (* * * *: p ⁇ 0.001).
- FIG.8 is a graph showing fluorescence intensity when VUAA1 or pentyl acetate was brought into contact with immobilized Orco-OR47a-expressing cell line (ns: non-significant, *: p ⁇ 0.05, * * * * *: p ⁇ 0.01).
- FIG.9A-B is a graph showing the response function over time to pentyl acetate as a change in fluorescence intensity in a ligand assay utilizing a perfusion system using an Orco-OR47a stable expression cell line.
- FIG. 9B is a graph showing the response function over time to pentyl acetate as a change in fluorescence intensity in a ligand assay utilizing a perfusion system using a Pvll-GCaMP6f stable expression cell line (GCaMP6f stable expression cell line).
- FIG.10 is a graph confirming that OR47a expression was optimized by adding an untranslated region (UTR) in a donor vector (*p ⁇ 0.001, ****:p ⁇ 0.0001).
- FIG.11A-E Polypedium vanderplanki in adult FIG 11A, Larval FIG.11B and dried larval state
- FIG.11C The Oreo/OR ion channel opens upon odorant binding.
- the present disclosure relates to cells derived from Polypedilum vanderplanki expressing exogenous membrane proteins produced by genetic engineering techniques.
- Cells derived from Polypedilum vanderplanki for expressing the exogenous membrane protein can be those commonly used in the art without particular limitation; examples include Pv11 cells, Pv210 cells, and the like.
- Cells from Polypedilum vanderplanki expressing the exogenous membrane protein can be dried and then rehydrated to allow the exogenous membrane protein to function.
- the drying conditions are not particularly limited as long as the exogenous membrane proteins are not denatured and the cells derived from Polypedilum vanderplanki can function by rehydration after drying; for example, they may be dried in an environment where the temperature is 30°C or less, preferably 25°C or less, and/or in an environment where the humidity is 10% or less, preferably 5% or less, for 2 days or more, preferably 7 days or more. Drying under such mild conditions allows the exogenous membrane proteins to function better after rehydration.
- rehydration refers to the rehydration of dried cells into an aqueous solution.
- the conditions for the rehydration are not particularly limited as long as the dried cells derived from Polypedilum vanderplanki can function; for example, a buffer solution comprising an insect cell medium such as IPL-41 or Dulbecco's phosphate buffer (DPBS) may be added to the cells, and a solution comprising the insect cell medium is preferably added.
- DPBS Dulbecco's phosphate buffer
- the cells according to the present disclosure are characterized in that even a membrane protein having an extracellular domain such as a functional odorant receptor (heterocomplex) can be dry-preserved while maintaining its function. More than 20% of the dried cells survived after rehydration when stored at room temperature for 7 days or longer, and at least 1% survived after rehydration when stored at room temperature for 372 days or more.
- the cells express newly produced exogenous membrane proteins in vivo by 24 hours after drying and rehydration; however, immediately after drying and rehydration, without waiting for the expression of the exogenous membrane protein produced in vivo, membrane proteins stored in a dried state begin to revive, and the state of cells can be stabilized in, for example, about 10 minutes.
- the exogenous membrane protein is not particularly limited; examples include cell surface receptor proteins, channels, and transporters that respond to a wide variety of signals from the external environment such as chemical substances.
- cell surface receptor proteins include G protein-coupled receptor (GPCR) proteins, enzyme-coupled receptors, ion channel- coupled receptors, and the like.
- the cell surface receptor protein includes, for example, olfactory receptor proteins (Or), olfactory receptor protein co-receptors (Orco), gustatory receptors with similar structure to Or and Orco, mechano-stimulatory receptors, and the like.
- the cell may express one type of exogenous membrane protein or may co- express two or more types of exogenous membrane proteins. Complexes may also be formed between co-expressed exogenous membrane proteins.
- One aspect of the present disclosure is a cell from Polypedilum vanderplanki expressing olfactory receptor protein (Or) and/or insect olfactory receptor protein co-receptor (Orco).
- the olfactory receptor protein is a type of G protein-coupled ion channel in the olfactory receptor nerve; in the present disclosure, it may be derived from vertebrates such as mammals or from insects, but it is preferably derived from insects because it is simple because it functions with two proteins, Or and Orco, and because it is superior in diversity and odor selectivity.
- More than 100 distinct insect olfactory receptor proteins from Drosophila melanogaster, Anopheles gambiae, Bombyx mori, and the like have been identified as described in Japanese Patent Application No.2013-27376.
- Each OR has specific responses to odorants such as, for example, phenethyl alcohol, methyl benzoate, ethyl benzoate, benzyl alcohol, methyl salicylate, benzaldehyde, pentanal, hexanal, E2-hexanal, 2-heptanone, 6-methyl-5-hepten-2-one and 2-methylphenol (Hallem et al., Cell 125, 143-160, April 7, 2006).
- the receptor protein functions as an ion channel-coupled receptor, and when the target odorant binds to the receptor, an influx of ions into the receptor-expressing cell occurs.
- Insect ORs may be derived, for example, from the insect orders Coleoptera, Lepidoptera, Diptera, and Hymenoptera, including species of economic or medical importance.
- the Or proteins for expression in Polypedilum vanderplanki cells are derived from Drosophila.
- Such Drosophila OR proteins include, but are not limited to, Or1a, Or2a, Or7a, Or9a, Or10a, Or13a, Or19b, Or19a, Or22a, Or22b, Or22c, Or23a, Or24a, Or30a, Or33a, Or33b, Or33c, Or35a, Or42a, Or42b, Or43a, Or43b, Or45a, Or45b, Or46a, Or47a, Or47b, Or49a, Or49b, Or56a, Or59a, Or59b, Or59c, Or63a, Or65a, Or65b, Or65c, Or67a, Or67b, Or67c, Or67d, Or69a, Or74a, Or82a, Or83a, Or83c, Or85a, Or85b, Or85c, Or85d, Or85e, Or85f, Or88a, Or92a, Or94a, Or94b, Or98a and Or98b.
- DmOr85b which responds to ammonia, classified as an extremely hazardous substance, DmOr46a which responds specifically to 4-methylphenol, present in human sweat, and DmOr98a which can detect phenyl-acetone, a precursor of amphetamines may be expressed in Polypedilum vanderplanki cells.
- the database DoOR2.0 includes findings on the function of ORs in Drosophila and quantitative data on odorant responses in vivo. (D. Münch and C. G. Galizia, "DoOR 2.0 - Comprehensive mapping of Drosophila melanogaster odorant responses," Sci.
- the olfactory receptor protein co-receptor (Orco) is a coupling factor with Or, and the ligand-binding Or and Orco form a heterocomplex and function as a ligand-gated ion channel.
- Or a coupling factor with Or
- the ligand-binding Or and Orco form a heterocomplex and function as a ligand-gated ion channel.
- an odorant binds to the OR
- the pore formed by the Or and Orco opens, allowing cations to flow into the cell and trigger an action potential.
- the insect olfactory receptor protein co-receptor (Orco) is highly conserved among species.
- an Orco protein not only derived from Drosophila melanogaster but also proteins suitable for Pv11 cells such as Polypedilum vanderplanki can be used.
- the cell derived from Polypedilum vanderplanki according to the present disclosure can have a gene encoding an exogenous membrane protein integrated into the genome of the cell, because the exogenous membrane protein can be stably expressed.
- the gene encoding the exogenous membrane protein is operably linked to the 121 promoter (SEQ ID NO: 1).
- the 121 promoter is a strong promoter discovered from the Polypedilum vanderplanki genome; it is known to have about 1,500-fold higher ability to produce protein compared to the promoter contained in commercial kits for insect cells.
- the 121 promoter derived from Polypedilum vanderplanki has the sequence shown in SEQ ID NO:1.
- the Polypedilum vanderplanki-derived cells expressing the exogenous membrane protein of the present disclosure may further express another exogenous protein other than said exogenous membrane protein.
- the other exogenous protein is not particularly limited; for example, when the exogenous membrane protein is a G protein-coupled ion channel, a fluorescent marker protein capable of detecting ions flowing into cells when the ion channel binds to a ligand may be expressed as the exogenous protein.
- the exogenous protein may be a protein that emits fluorescence in response to calcium ions in the cytoplasm, specifically, it may be, for example, G-CaMP; G-CaMPl.6; GCaMP2; GCaMP3; G- CaMP4.1; GCaMP5; G-CaMP6, 7, 8; GCaMP6f, 6m, 6s; jGCaMP7f, 7s, 7b, 7c, GCaMP-X, and the like.
- G-CaMP G-CaMPl.6
- GCaMP2 GCaMP3
- G- CaMP4.1 G-CaMP5
- G-CaMP6, 7, 8 GCaMP6f, 6m, 6s
- jGCaMP7f, 7s, 7b, 7c GCaMP-X
- the cells of one embodiment are Pv11 cells co-expressing Or and Orco as exogenous membrane proteins and intracellularly expressing exogenous GCaMP. Even if the cells are dried, they can be restored to functional cells by rehydration, and the hydration and desiccation states are reversible.
- the dry cells can be stored at room temperature and can be transported without complicated culture equipment.
- the exogenous membrane proteins can be functional even after drying and rehydrating the cells. That is, Or and Orco form an odorant receptor complex in the cell membrane, and when the complex comes into contact with an odorant that specifically reacts with it, the calcium ion concentration in the cytoplasm rises in response. Such responses can be reproduced in as little as one hour after drying and rehydrating the cells.
- GCaMP Since GCaMP emits a fluorescent signal in response to calcium ions, it is possible to visualize an increase in calcium ion concentration due to the response reaction. Furthermore, 24 hours after rehydration, the odorant response of the cells can be potently enhanced by de novo synthesized Orco and Or proteins. Thus, if the Pv11 cells expressing Or and Orco and GCaMP remain hydrated even after repeated hydration and drying, because they can exert the function of the odorant receptor complex, which is a membrane protein, they can be shipped dry and rehydrated when needed to aid in the detection of particular odorants or the identification of odors.
- a portion of the gene encoding an exogenous membrane protein can be obtained, for example, by extracting mRNA, synthesizing, and isolating cDNA, and using the cDNA as a template and appropriate PCR primers by PCR.
- genes encoding additional exogenous proteins can be partially obtained by PCR using appropriate PCR primers using cDNA as a template.
- the exogenous membrane protein can be cloned by other conventional methods.
- the exogenous membrane protein and/or the additional exogenous protein can be incorporated into an expression vector, and cells derived from Polypedilum vanderplanki can be transformed with the expression vector to prepare the cells to express the protein of interest.
- Exogenous protein expression vectors are not particularly limited as long as they are replicable in host cells.
- recombinant DNA technology well known to those skilled in the art may be used.
- Expression vector may be a nucleic acid in the form of a plasmid, a cosmid, a phagemid, a phage, a viral vector or the like.
- expression vector construction including recombinant DNA technology reference may be made to Sambrook et al., Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory Press, (2001), F M Ausubel et al, Current Protocols in Molecular Biology, John Wiley amp; Sons, Inc.
- the expression vector may include regulatory sequences that affect transcription and translation of the Or and/or Orco encoding nucleic acid by being operably linked to the nucleic acid.
- regulatory sequences may include promoter sequences, transcription termination signal sequences (polyadenylation signal), and the like.
- being operably linked means a linkage such that the transcription and/or translation of a nucleic acid are affected.
- Regulatory sequences also include enhancer sequences that function to regulate the transcription of a nucleic acid.
- the expression vector may further include a selectable marker gene.
- the selectable marker gene is a gene encoding a trait that enables selection of a host microorganism containing such a marker gene and is generally an antibiotic resistance gene.
- the expression vector may also include a restriction enzyme recognition site for easy cloning of the Or and/or Orco protein encoding nucleic acid. The expression vector may then be transformed into a host microorganism for expression of the Or and/or Orco protein.
- the strong promoter 121 may be used to express Ors and Orco in Pv11 cells.
- a known genome editing technique using ZFN, TALEN, CRISPR/Cas9, and the like may be applied to knock-in the gene encoding the exogenous membrane protein and/or the additional exogenous protein into Polypedilum vanderplanki -derived cells.
- CRIS-PITCh TALENs and CRISPR/Cas9
- the CRIS-PITCh method is a gene knock-in method that introduces into cells a donor vector comprising a cassette in which a short homologous sequence (microhomology) of about 20 salt pairs is added to both ends of an exogenous gene, and utilizes the repair pathway MMEJ (non-homologous end joining) by cleaving both the genomic region of the target gene and the outer side of the exogenous gene at the same time.
- sequences encoding a plurality of proteins of interest may be incorporated into one expression vector or donor vector, or sequences encoding each protein of interest may be incorporated into each vector. Expression of exogenous membrane proteins and/or additional exogenous proteins may also be optimized in the expression vector or donor vector.
- the optimization means is not particularly limited; for example, the addition of an untranslated region (UTR), codon optimization, addition of a cell membrane localization signal peptide, or the like can be employed.
- expression of exogenous membrane proteins can be optimized by the addition of UTRs.
- the gene encoding the exogenous protein is preferably designed to be operably linked to the 121 promoter (SEQ ID NO:1).
- SEQ ID NO:1 the 121 promoter
- the cells may further express, as the additional exogenous protein, a fluorescent marker protein that detects changes in intracellular calcium concentration.
- a fluorescent marker protein such as calcium ion-dependent fluorescent dye for cells, for example, Ca1bryteTM 520 AM, Ca1bryteTM 590 AM, Ca1bryteTM 630 AM, Fluo-5F AM, Fluo-4 AM, Fluo-4FF AM, Fluo-3 AM, Fura-2 AM, Indo-1 AM, Rhod-2 AM, Rhod-3 AM, X-Rhod-1 AM, X-Rhod-5F AM, Oregon Green (registered trademark) 488 BAPTA series may be added to allow the intracellular calcium ion concentration to be observed by changes in fluorescence.
- the fluorescence intensity after contact with an odorant with which the OR specifically reacts preferably increases by at least 1% or more, preferably at least 5% or more, compared to the fluorescence intensity before contact.
- the cells are immobilized on a chip.
- the means for fixing the cells is not particularly limited, the cells may, for example, be immobilized on the chip using a biocompatible anchor for cell membrane (BAM) or polyethylenimine, which is an immobilization system utilizing electrostatic interaction.
- the odor sensor preferably comprises at least 1 x10 4 concentration/cm 2 , preferably at least 1 x 10 5 concentration of cells derived from Polypedilum vanderplanki, on the chip on which the cells are fixed.
- an array capable of simultaneously detecting different types of odorants or for identifying odors can be produced. If the array is brought into contact with a test sample having an unknown composition, and the test sample contains an odorant to which any one of the ORs specifically responds, the fluorescence of spots where cells expressing the OR are fixed is observed.
- the odor sensor can be stored in a dry state and can be immediately used for odor determination by rehydrating the cells at the time of use. Methods commonly used in the art can be employed without particular limitation for the method of drying and rehydrating the cells, the method of detecting and analyzing fluorescence signals, and the like.
- the present disclosure provides an odor detection method comprising the steps of (a) providing biosensor cells expressing at least one Or and/or Orco and exposing the biosensor cells to at least one test compound or sample and (b) detecting a signal that indicates activation of the one or more ORs in the biosensor cells.
- the detected signal is a change in intracellular calcium concentrations.
- the change in intracellular calcium concentration is detected through the use of a marker protein that detects changes in intracellular calcium concentration, e.g. a fluorescent calcium-sensing molecule.
- the biosensor cells expressing one or more ORs are placed in an assay plate, such as a 96-well plate or similar type plate and exposed to a test sample.
- the odor sensor cells are immobilized on a chip. Further, multi-OR sensor arrays may be utilized to determine responses to odorants singly or in mixtures.
- the odor sensor can be applied, for example, to the management of prohibited goods at airports, the medical field aiming at early detection of cancer by odor, and the like. In the field of agriculture, it can also be applied to food hygiene control and food quality evaluation based on the detection of slight odors (for example, geosmin produced by mold). Another application is the early detection of agricultural pests by detecting specific patterns in an array of cells caused by an odorant or odor.
- the disclosure also relates to a method of preserving exogenous membrane proteins in a dry state.
- the method comprises a step of introducing a gene encoding the exogenous membrane protein described above into cells derived from Polypedilum vanderplanki, a step of culturing the cells to express the exogenous membrane protein in the cell membrane, and a step of drying the cells.
- the membrane protein stored in the dried state begins to revive, and the state of the cell can be stabilized in, for example, about 10 minutes.
- a drought-protecting agent such as insect culture medium comprising trehalose or serum from the viewpoint of induction of expression of functions related to extreme drought tolerance.
- the present disclosure provides devices for detecting the presence of a particular odorant or for identifying an odor comprising biosensor cells expressing one or more ORs that are activated upon exposure to particular odorant molecules or to particular odorant mixtures.
- the device is a handheld device.
- the device is capable of communicating to a user of the device that a particular odorant has been detected or that a type of odor has been identified.
- the present disclosure also provides kits for detection of an odorant or identification of an odor using one or more biosensor cells.
- the kits comprise a panel of heterologous cells each expressing a particular OR. The kits may include instructions for using the kit.
- kits may also comprise buffers, and signal producing and detection systems.
- all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present disclosure, suitable methods and materials are described below. All publications, patent applications, patents, and other references mentioned herein are incorporated by reference in their entirety. In case of conflict, the present specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting. [00064] The present disclosure will be described in more detail below with reference to embodiments, but the present disclosure is not limited to these embodiments. EXAMPLES [00065] 1.
- Transient expression strain preparation GCaMP6f cDNA was amplified by PCR in a conventional manner, and a pPv121-GcaMP6f vector was produced by inserting the amplified DNA sequence (SEQ ID NO: 2) encoding GcaMP6f downstream of a 121 promoter of a pPv121-MCS vector (Tokumoto et. A1., doi: https: //doi. Org/10.1101/2020.05.29.123570 “Development of a Tet-On inducible expression system for the anhydrobiotic cell line, Pvll”).
- the cDNA of Orco derived from Drosophila melanogaster was amplified by PCR by a conventional method, and a pPv121-Orco vector was generated by inserting the amplified Orco- encoding DNA sequence (SEQ ID NO:3) downstream of the 121 promoter of the pPv121-MCS vector.
- Or47a cDNA derived from Drosophila melanogaster was amplified by PCR in a conventional manner, and the amplified DNA sequence encoding Or47a (SEQ ID NO: 4) was operably linked to pPv121-M.
- FIG.2 schematically shows the gene organization in the preparation of the Orco-Or47a stable expression cell line.
- a lightning mark schematically indicates the cleavage site.
- GCaMP6f The functionality of GCaMP6f in the resulting cell lines was evaluated using Ionomycin (Ionomycin; Fujifilm Wako Pure Chemical) to increase the intracellular concentration of calcium ions to provide functional confirmation of exogenous proteins in the GCaMP6f stable-expressing cell line.
- Ionomycin was dissolved in dimethyl sulfoxide (DMSO; Fujifilm Wako Pure Chemical Industries, Ltd.), adjusted to a final DMSO concentration of 1% and an ionomycin final concentration of 1 ⁇ M in IP1-41 medium, and added to the cell solution.
- DMSO dimethyl sulfoxide
- DMSO dimethyl sulfoxide
- the fluorescence intensity was quantified by encircling the cells in the photographed image and measuring the fluorescence intensity (F) over time. The results are shown in FIGS.3 and 4.
- the Orco-Or47a stable expression cell line did not respond to a control solution containing DMSO (negative control); however, an increase in fluorescence intensity was observed for VUAA1. From this, it was found that Orco was functionally expressed.
- an increase in fluorescence intensity was also observed for pentyl acetate. From this, it was found that Or47a is functionally expressed. Therefore, it was found that both Orco and Or47a function normally in the prepared stable expression cell line.
- Statistical analysis was performed in the same manner as in 3.2 above.
- the sedimented cells were suspended in 400 ⁇ l of 600 mM trehalose mix, and 40 ⁇ l were dropped onto a 35 mm dish.
- the 35 mm dish was dried for 10 days under conditions of 25°C and humidity of 10% or less.
- Cells dried for 10 days were rehydrated by adding 1 ml of IPL-41 medium.
- the resuscitation rate was obtained by dividing the number of viable cells (Hoechst+, p I -) in the image by the total number of cells (Hoechst+).
- the control Pv11 cells had a viability of 13%, whereas the GCaMP6f stable expressing cell line had a viability of over 20%.
- the GCaMP6f stable cell line maintained drying tolerance.
- fluorescence intensity generated in response to stimulation with VUAA1 (Orco agonist) or pentyl acetate (ligand of Or47a) was measured in the same manner as in 3.2 above.
- the fluorescence intensity was digitized from the photograph, and ⁇ F/F was calculated according to the following formula: Where the summation is over the n cells in the image, F i,after means the fluorescence intensity of the cell i after adding the ligand solution, and Fi, 0 means the fluorescence intensity of the cell i before adding the ligand solution.
- a fluorescence image was taken under the condition in which the excitation wavelength/fluorescence wavelength was 488 nm/525 nm.
- the cells were identified in the photographed image, and the fluorescence intensity (F) was measured for each time.
- the initial values of fluorescence intensity (F 0 ) were subtracted from the measured fluorescence intensity at each time to obtain the amount of change in fluorescence ( ), which was then normalized by dividing by the initial value of fluorescence intensity (F 0 ) to obtain ( ).
- a number of cells n were selected from the captured image, 0 were produced for each, and the average value (including standard deviation, SD) of the results was graphed.
- FIG. 6A shows the results of the Orco-Or47a stable expression cell line before drying
- FIG.6B shows the results of the Orco-Or47a stable expression cell line 1 hour after drying and rehydration.
- the Orco-Or47a stable expression cell line before drying responded to the Orco agonist (VUAA1) and the specific ligand of Or47a, pentyl acetate. A significant difference was confirmed in that it did not react to acetophenone, which is neither a ligand for Orco nor Or47a (FIG.6A).
- FIGS.7A-7B are graphs showing changes in fluorescence intensity of the Orco-Or47a stable expression cell line response to VUAA1 and pentyl acetate, respectively, one hour after drying and rehydration.
- FIGS.7A-7B are graphs showing changes in fluorescence intensity of the Orco-Or47a stable expression cell line response to VUAA1 and pentyl acetate, respectively, one hour after drying and rehydration.
- FIGS.7A and 7B are graphs showing changes in fluorescence intensity, respectively, in response to VUAA1 and pentyl acetate of Orco-Or47a stable expression cell lines 24 hours after drying and rehydration.
- Pv11 cells showed specific responses to VUAA1 (FIG. 7A) or pentyl acetate (FIG.7B). From the results of FIGS.7A and 7B, there was no significant difference in the function of the exogenous membrane protein depending on the presence or absence of cycloheximide and the difference in concentration. At least some of the exogenous membrane proteins Orco and Or47a were shown to function on cell membranes even after the stress of drying, storage, and rehydration.
- BAM consists of a hydrophilic PEG chain, an NHS group, and a hydrophobic oleyl group; by bringing BAM into contact with a collagen-coated dish, the NHS group binds to collagen, and the oleyl group interacts with the cell membrane through hydrophobic interactions, allowing cells to adhere.
- BAM (SUNBRIGHT OE-040CS, Yuka Sangyo Co., Ltd.) was dissolved in DMSO (Fujifilm Wako Pure Chemical Industries) to a concentration of lOmM.
- the 10mM BAM solution was adjusted to DPBS (-) (Thermo Fisher) to a final concentration of 100 ⁇ M, 100 ⁇ l was dropped onto a collagen l-coated 48-well microplate (IWAKI) and incubated at 37°C for 1 hour.
- the BAM solution was removed, washed once with DPBS (-) (Thermo Fisher) and five times with MilliQ, and allowed to stand still to evaporate water droplets.
- the Pv11 cell suspension was centrifuged at 700 g for 3 minutes, the supernatant was removed, the cell pellet was suspended in DPBS(-) (Thermo Fisher) and dropped onto a BAM-coated dish.
- FIG.9A shows the result of the Orco-Or47a stable expression cell line
- FIG.9B shows the result of the Pv 11-GCaMP6f stable expression cell line.
- the Orco-Or47a stable expression cell line and the GCaMP6f stable expression cell line were fixed with BAM as described in 8.1 above and perfused at a flow rate of 1 mL/min using a peristaltic pump (SJ-1211 II-L2, ATTO).
- the perfusion solution was ACSF buffer (125 mM NaCl, 5.6 mM KC1, 1.25 mM Na 2 HPO 4 , 10 mM HEPES, 1.5 mM CaCl 2 , pH7.4) as a standard solution.
- pentyl acetate was diluted to a final concentration of 1 mM, and as a negative control, DMSO was diluted to 1% by mass.
- the standard solution was perfused, switched to lmM pentyl acetate solution or 1% by mass DMSO solution, and perfusion was performed for 5 minutes. Photographing of the cells was started after waiting for the l mM pentyl acetate solution or 1% by mass DMSO solution to reach the cells in about 60 seconds. Bright-field and fluorescence images of the perfused Pv11 cells were taken 30 times at 10-second intervals (LSM700, ZEISS).
- FIG.10 shows the expression level of Or47a, which was corrected for transfection efficiency by dividing the Or47a value quantified by the HiBiT system by the transfection control Luc 2 value.
- Statistical analysis was performed in the same manner as in 3.2 above. From the results in FIG. 10, the addition of Tret1-UTR and g5495-UTR improved the expression level of Or47aPolypedilum vanderplanki is an insect dwelling in a semi-arid region (FIG.11A) that can be completely desiccated (anhydrobiosis) in the larval state (FIG. 11B-C).
- FIG.11D the Oreo/OR ion channel opens upon odorant binding. Cai ⁇ influx leads to GCaMP marker fluorescence (FIG.11E).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Plant Pathology (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263269167P | 2022-03-10 | 2022-03-10 | |
| PCT/US2023/014959 WO2023172727A1 (en) | 2022-03-10 | 2023-03-10 | Cells derived from polypedilum vanderplanki and odor sensor equipped therewith |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4490267A1 true EP4490267A1 (en) | 2025-01-15 |
| EP4490267A4 EP4490267A4 (en) | 2026-03-11 |
Family
ID=93843206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP23767510.3A Pending EP4490267A4 (en) | 2022-03-10 | 2023-03-10 | CELLS FROM POLYPEDILUM VANDERPLANKI AND OLDER SENSOR |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP4490267A4 (en) |
| JP (1) | JP2025138913A (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101110805B1 (en) * | 2008-05-07 | 2012-02-24 | 재단법인서울대학교산학협력재단 | Olfactory receptor-functionalized transistors for highly selective bioelectronic nose and biosensor using the same |
| JP5854686B2 (en) * | 2011-07-29 | 2016-02-09 | 亮平 神崎 | Odor sensor |
| JP6789051B2 (en) * | 2016-09-29 | 2020-11-25 | 住友化学株式会社 | Olfactory receptor complex and cells expressing it |
| JP6875815B2 (en) * | 2016-09-29 | 2021-05-26 | 住友化学株式会社 | Olfactory receptor co-receptor |
| WO2018216192A1 (en) * | 2017-05-26 | 2018-11-29 | 株式会社島津製作所 | Smell sensor |
-
2023
- 2023-03-10 JP JP2023037739A patent/JP2025138913A/en active Pending
- 2023-03-10 EP EP23767510.3A patent/EP4490267A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4490267A4 (en) | 2026-03-11 |
| JP2025138913A (en) | 2025-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20160326219A1 (en) | Optically activated receptors | |
| JP2006516884A (en) | Isolation and use of ryanodine receptor | |
| JP2020510436A (en) | Method of identifying malodor control compounds | |
| EP2437055B1 (en) | Method for screening for a drug candidate substance which inhibits target protein-protein interaction for developing a novel concept drug | |
| Andersson et al. | A sex pheromone receptor in the Hessian fly Mayetiola destructor (Diptera, Cecidomyiidae) | |
| JP7265487B2 (en) | Chimeric receptors for use in whole-cell sensors for detecting analytes of interest | |
| US7223550B2 (en) | Biosensor for defecting chemical agents | |
| WO2018062201A1 (en) | Odorant receptor complex and cells expressing same | |
| US20250197799A1 (en) | Cells derived from polypedilum vanderplanki and odor sensor equipped therewith | |
| Feng et al. | GST-Mu of Cristaria plicata is regulated by Nrf2/Keap1 pathway in detoxification microcystin and has antioxidant function | |
| JP2009153399A (en) | Single molecule real-time bioluminescence imaging probe | |
| RU2727685C1 (en) | Genetically coded indicators of potassium ions | |
| EP4490267A1 (en) | Cells derived from polypedilum vanderplanki and odor sensor equipped therewith | |
| JP2009225733A (en) | Method for evaluation of trpa1 activator | |
| EP3433265B1 (en) | Pheromonal receptor of spodoptera littoralis and identification of natural ligand of said receptor and uses thereof | |
| Boettner et al. | Ras and rap 1 interaction with AF-6 effector target | |
| ES2545485T3 (en) | Nucleic acid molecules and procedures to identify modulators of GPR84 activity | |
| JP2009512460A (en) | Method for detecting intracellular enzyme complex | |
| EP3658686B1 (en) | Methods and tools for purifying nucleic acids using polymerized tubulin | |
| EP4141102A1 (en) | Nucleic acid capable of interacting with endocrine disruptor receptor, and use thereof | |
| JP2003079365A (en) | Highly sensitive detection of environmentally hazardous chemicals | |
| Huang et al. | Imaging Ca2+ Signaling in Trypanosoma cruzi with Genetically Encoded Ca2+ Indicators | |
| JP5414002B2 (en) | Monitor protein for analyzing membrane protein expression | |
| JP5360846B2 (en) | Monitor protein for analyzing membrane protein expression | |
| WO2024178215A2 (en) | Chimeric biosensor for the detection 2'3'-cyclic gmp-amp (cgamp) and methods of use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20241002 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20260209 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12N 5/07 20100101AFI20260203BHEP Ipc: C12N 15/85 20060101ALI20260203BHEP Ipc: C07K 14/72 20060101ALI20260203BHEP Ipc: C12N 5/10 20060101ALI20260203BHEP Ipc: G01N 31/12 20060101ALI20260203BHEP Ipc: G01N 33/50 20060101ALI20260203BHEP Ipc: C07K 14/705 20060101ALI20260203BHEP Ipc: C12N 15/90 20060101ALI20260203BHEP |